Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #5, May 2002
Not All of Plaintiffs' Ephedra Claims 'Subsumed' Within Liability Doctrine, U.S. District Court Rules
A federal court in Alabama has found that not all of the plaintiffs' claims in a case stemming from the consumption of Metabolife 356 may be subsumed under the Alabama Extended Manufacturer's Liability Doctrine (AEMLD).
A federal judge in West Virginia has refused to remand an OxyContin class action based on his finding that a pharmacy was fraudulently joined to the complaint after being added two weeks after the original was filed.
A federal judge has found that the possibility of attorney's fees and punitive damages coupled with the plaintiffs' claims for damages in an OxyContin case exceeded the statutory minimum necessary to remand the case to state court...
A state court judge in Alaska has reduced the first-ever verdict awarded to a plaintiff allegedly injured by an ephedra-containing product
A state judge in New Jersey has turned back a bid to certify a class of plaintiffs in the state's Propulsid litigation saying the putative members lack the predominance and demonstrated loss necessary to proceed as a group
A California man has sued a vaccine manufacturer and two auto shops that sold him asbestos-laden brake parts claiming both are to blame for causing his almost-always-fatal form of cancer
The widow of a man who died in May 2000 after taking the weight loss product Dexatrim filed suit April 25 against the manufacturers of the product and the pharmacy where it was purchased